| Hans-Günter Meyer-Thompson | Hepatitiden
The path to cancer, and back: Immune modulation during hepatitis C virus infection, progression to fibrosis and cancer, and unexpected roles of new antivirals.
The path to cancer, and back: Immune modulation during hepatitis C virus infection, progression to fibrosis and cancer, and unexpected roles of new antivirals.
Debes JD, de Knegt RJ, Boonstra A.
Transplantation. 2016 Dec 30. doi: 10.1097/TP.0000000000001623. [Epub ahead of print]
Abstract